Lu E, Hebert Z, Solovyeva K, Kietzer L, Antoun ZE, Alfonso-Cristancho R. J Asthma. 2025 Aug;62(8):1439-1449. doi: 10.1080/02770903.2025.2488000. Abstract Rationale Biologics are indicated for severe asthma, but little is known…
Chan, A. H. Y., Scahill, S., Zhu, J., Qin, Z., Lin, C., Abadi, E., … Aspden, T. (2025). Journal of Asthma, 1–12. https://doi.org/10.1080/02770903.2025.2514268 Abstract Introduction Asthma is one of the…
Dear Colleagues, Asthma remission is a hot topic of the moment. If criteria defining clinical remission concerning the rate of exacerbation, systemic corticosteroids use and symptoms control seem to be…
Cheng, W. H., Borsos, K., Wang, Z., Ledanois, O., Gall, R., Small, M., & Humphreys, R. (2025). Journal of Asthma, 1–14. https://doi.org/10.1080/02770903.2025.2513059 Abstract Objective Childhood asthma is a multifaceted, chronic…
Yau E, Cheung JMY, Saini B, Hughes S. J Asthma. 2025 May 4:1-14. doi: 10.1080/02770903.2025.2487986. Abstract Objective People with asthma may experience sleep disturbances due to uncontrolled asthma symptoms and/or…
Yau, E., Dr, Cheung, J. M. Y., Professor, Saini, B., Dr, & Hughes, S. (2025). Journal of Asthma, 1–24. https://doi.org/10.1080/02770903.2025.2487986 Abstract Objective People with asthma may experience sleep disturbances due…
Tiotiu, A., Braido, F., Kowal, K. et al. Clinic Rev Allerg Immunol 68, 45 (2025). https://doi.org/10.1007/s12016-025-09055-0 Abstract Despite house dust mite (HDM)-allergy is the most frequent in the world, no standard questionnaire exists…
Zheng X, Yin J, Zhao L, Qian Y, Xu J. J Asthma. 2025 Mar 17:1-13. doi: 10.1080/02770903.2025.2478504. Abstract Objective Asthma is a prevalent chronic respiratory condition with multifactorial pathogenesis. Emerging…
Håkansson KEJ, Ibsen R, Steen Krogh N, Baastrup Soendergaard M, Hansen S, Bjerrum AS, von Bülow A, Hilberg O, Løkke A, Bonnesen B, Johnsen CR, Lock-Johansson S, Dongo L, Bisgaard…
Pulm Pharmacol Ther. 2024 Nov 19:102333. doi: 10.1016/j.pupt.2024.102333. Highlights Abstract Long-acting muscarinic antagonists (LAMA) in association with inhaled corticosteroids (ICS) plus long-acting beta-2 agonists (LABA) are recommended by the GINA…